Journal of International Oncology››2012,Vol. 39››Issue (4): 252-254.

Previous ArticlesNext Articles

Polyinosinic-polycytidylic acid and tumor immunity

CHENG Yu-Sheng, XIA Jing-Yan, XU Feng

  1. Department of Respiratory Medicine,Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310009,China
  • Online:2012-04-08Published:2012-03-28
  • Contact:Corresponding author: XIA Jing-yan, E-mail: xiajingyan2000@yahoo.com.cn E-mail:xiajingyan2000@yahoo.com.cn

Abstract:Polyinosinic-polycytidylic acid is a synthetic analog of double-stranded RNA, which plays a vital role in the regulation of immune system. Toll-like receptor 3 (TLR3), melanoma differentiation-associated gene 5 (MAD-5) and retinoic acid inducible gene -Ⅰ (RIG-Ⅰ) are the main three intracellular receptors binding to polyinosinic-polycytidylic acid which activates human anti-tumor immune responses including the activation of innate immunity and acquired immunity through TIR-domain-containing adapter-inducing interferon-β (TRIF) and interferon-β. Thus, polyinosinic-polycytidylic acid plays an important role in regulating anti-tumor immune responses. The immunoregulation mechanisms of polyinosinic-polycytidylic acid in melanoma, breast cancer, malignant glioma and lung cancer have been clarified, which will provide new strategies for tumor immunotherapy.

Key words:color: black,mso-font-kerning: 1.0pt,mso-ansi-language: EN-US,mso-fareast-language: ZH-CN,mso-bidi-language: AR-SA,mso-bidi-font-family: 'Times New Roman',mso-fareast-font-family: 宋体">Poly I-C,color: black,font-family: "Times New Roman",mso-font-kerning: 1.0pt,mso-ansi-language: EN-US,mso-fareast-language: ZH-CN,mso-bidi-language: AR-SA,mso-fareast-font-family: 宋体">Immunity,color: black">Neoplasms